Sharehope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 11, 2020 at 12:09 pm EST
Share
ShareHope Medicine Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was TWD 1,178.779 million compared to TWD 783.165 million a year ago. Operating income was TWD 250.626 million compared to TWD 41.238 million a year ago. Net income was TWD 134.888 million compared to TWD 78.487 million a year ago. Basic earnings per share was TWD 1.24 compared to TWD 0.73 a year ago. Diluted earnings per share was TWD 1.2 compared to TWD 0.7 a year ago. For the nine months, total revenue was TWD 2,977.298 million compared to TWD 2,318.010 million a year ago. Operating income was TWD 417.575 million compared to TWD 107.728 million a year ago. Net income was TWD 172.118 million compared to TWD 165.352 million a year ago. Basic earnings per share was TWD 1.6 compared to TWD 1.54 a year ago. Diluted earnings per share was TWD 1.54 compared to TWD 1.43 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
